Logout
If you want to log out click in LogOut
The JNK pathway (c-Jun N-terminal kinase pathway) is a stress-activated branch of the mitogen-activated protein kinase (MAPK) signaling network. It regulates transcriptional responses to environmental stress, inflammatory cytokines, DNA damage, and growth factor stimulation.
JNK belongs to the MAPK family and is encoded by three genes:
Under physiological conditions, the JNK signaling pathway contributes to cellular adaptation. Under pathological stress, however, sustained JNK activation can drive apoptosis, inflammation, or tumor progression depending on cellular context.
This context-dependent behavior makes this signaling cascade a critical regulator of cellular fate decisions.
c-Jun N-terminal kinase pathway activity can be efficiently assessed by measuring gene expression changes in MAP3Ks, MKK4/7, AP-1 components, and stress-responsive downstream targets. Such transcriptional profiling allows discrimination between transient adaptive signaling and sustained pro-apoptotic activation states.
JNK signaling pathway biomarker list
View the genes included in our JNK-related qPCR arrays.
JNK activation follows a canonical three-tier MAPK cascade:
This dual phosphorylation is required for full enzymatic activation.
Activated JNK translocates to the nucleus where it phosphorylates:
Through AP-1 activation, the JNK signaling pathway regulates genes involved in:
Transient activation often promotes adaptation and survival.
Prolonged activation frequently shifts signaling toward apoptosis or tissue damage.
The JNK signaling pathway does not function in isolation. It interacts extensively with:
In the tumor microenvironment, these interactions shape proliferation, immune modulation, and therapeutic resistance.
Understanding pathway crosstalk is essential for accurate biomarker interpretation.
Because of its central role in stress adaptation, the c-Jun N-terminal kinase pathway has emerged as a therapeutic target.
Experimental inhibitors such as SP600125 have been widely used in research settings to dissect JNK-dependent mechanisms.
However, the dual role of JNK in cancer and inflammation complicates direct inhibition strategies. Therapeutic approaches increasingly focus on:
Accurate pathway activity profiling is therefore essential in translational research
Cancer
The JNK signaling pathway plays a dual role in oncology.
In some contexts, JNK promotes apoptosis and acts as a tumor suppressor.
In others, sustained activation enhances proliferation, invasion, and inflammatory microenvironments.
It is implicated in:
Neurodegenerative Disorders
JNK3 is particularly enriched in neuronal tissues.
Aberrant activation contributes to:
Chronic JNK signaling is associated with neuronal apoptosis and synaptic dysfunction.
Inflammatory and Fibrotic Disorders
The SAPK/JNK signaling modulates:
Under persistent inflammatory stress, JNK drives cytokine production and tissue remodeling.
Investigating stress-activated signaling requires robust and reproducible transcriptional analysis.
AnyGenes® provides pathway-focused qPCR arrays designed to:
In translational research settings, standardized gene expression profiling enables consistent interpretation across experimental conditions.
The JNK SignArrays® panel includes genes involved in:
Species available:
Custom panels can be designed to match specific experimental hypotheses.
From targeted pathway interrogation to broader signaling signatures, transcriptional profiling allows precise monitoring of JNK signaling activity.
Scientific data is only as powerful as the analysis behind it.
AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.
What does it allow you to do?
Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to initiate your project.
The JNK pathway is a stress-activated MAPK signaling cascade that regulates transcriptional responses to inflammation, DNA damage, and environmental stress.
It follows a MAP3K → MKK4/MKK7 → JNK phosphorylation cascade, leading to activation of transcription factors such as c-Jun and AP-1.
Dysregulated JNK signaling contributes to cancer progression, neurodegeneration, inflammation, and fibrosis, depending on activation context and duration.
Key components include MAPK8, MAPK9, MAPK10, MKK4, MKK7, ASK1, and AP-1 transcription factors.
Pathway activity can be assessed through transcriptional profiling of downstream target genes using pathway-focused qPCR arrays.
| Signaling Pathways | Product ref | Informations |
|---|---|---|
JNK Signaling Pathway | JNK1H1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
JNK Signaling Pathway | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
JNK Signaling Pathway | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
JNK Signaling Pathway | ******* |
Biomarker list in progress. |
Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.
For more information on prices, please contact us at: